Post Event Information
EDTA Conference
Stockholm, 10-13 May 2008
Dr Bruce Spinowitz, USA
Poster SP385, XLV ERA-EDTA Congress in Stockholm,
May 10–13, 2008
“Irrespective of route of administration MIRCERA both IV and SC was able to maintain haemoglobin at a steady level.”
 Download EDTA Poster SP385 "C.E.R.A. maintains stable haemoglobin levels in dialysis patients regardless of administration route (IV or SC)" |
 |
Dr Gilbert Deray, France
Poster SP386, XLV ERA-EDTA Congress in Stockholm,
May 10-13, 2008
“Anytime I use a new drug, I am looking for safety.”
| Download EDTA poster SP386 "C.E.R.A. has a comparable safety profile to other erythropoiesis stimulating agents (ESAs) in patients with chronic kidney disease (CKD)" |
 |